Cocaine abuse in pregnancy - Anesthetic implications

International Journal of Obstetric Anesthesia

Volumn 11, Issue 3, 2002, Pages 204-210

  Kuczkowski, K M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ARTICLE; CLINICAL FEATURE; COCAINE DEPENDENCE; FEMALE; HIGH RISK PATIENT; HUMAN; LEGAL ASPECT; OBSTETRIC ANESTHESIA; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; TREATMENT PLANNING;

EID: 0036330568     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijoa.2002.0960     Document Type: Review

References (75)

1. Psychiatric illness and substance abuse
2. The chemically dependent parturient
3. Human immunodeficiency virus in pregnancy - Anesthetic implications
4. Cesarean section in the parturient with HIV and recent cocaine and alcohol intake: Anesthetic and cardiovascular implications
5. Characteristics of pregnant substance abusers in two cities in the northeast
6. Drug abuse in pregnancy - Anesthetic implications
7. The prevalence of cocaine abuse during pregnancy in Barcelona
8. Cocaine use in pregnancy in Amsterdam
9. Drug and alcohol use in the former Soviet Union: Selected factors and future considerations
10. Cocaine during pregnancy: A critical review of the literature
11. Prevalence of use of cocaine and other substances in an obstetric population
12. Substance abuse patterns in pregnant women
13. The relationship between recent cocaine use and pregnancy outcome
14. Predictors of cocaine use in pregnancy
15. Cardiovascular complications of cocaine use
16. Pharmacology and therapeutic applications of cocaine
17. On the general effects of cocaine (1885)
18. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?
19. Cocaine abuse: Neurochemistry, phenomenology and treatment
20. Anatomic actions of cocaine
21. Substance abuse and HIV in pregnancy
22. Substance abuse
23. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats
24. The effects of acute and chronic cocaine use on the heart
25. Pregnancy increases cardiovascular toxicity of cocaine
26. Cardiovascular effects of cocaine during pregnancy
27. Anaesthesia management of a parturient with myocardial infarction related to cocaine use
28. Mechanisms responsible for the cardiotoxic effects of cocaine
29. Cocaine, catecholamines and cardiac toxicity
30. Mechanism of cocaine induced myocardial depression in dogs
31. Pharmacological mechanisms of cocaine's cardiovascular effects
32. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
33. Substance abuse in pregnancy
34. Cocaine intoxication presenting as preeclampsia and eclampsia
35. Cocaine screening of parturients without prenatal care: An evaluation of a rapid screening assay
36. Identification of polysubstance abuse in the parturient
37. Cocaine abusing parturients undergoing cesarean section. A cohort study
38. Cocaine disposition in the meconium from newborns of cocaine-abusing mothers and urine of adult drug users
39. Cocaine use during pregnancy: Sensitive detection by hair assay
40. Cocaine exposure during pregnancy: Improving assessment with radioimmunoassay of maternal hair
41. Social and illicit drug use in pregnancy
42. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy
43. Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor
44. Cocaine use during pregnancy: Adverse perinatal outcome
45. Uterine rupture in association with alkaloidal cocaine use
46. Cocaine. How dangerous is it during pregnancy?
47. Uterine rupture associated with recent antepartum cocaine abuse
48. Cocaine-associated rhabdomyolysis causing renal failure in pregnancy
49. Hepatic rupture in pregnancy associated with cocaine use
50. Transfer of cocaine by the perfused human placenta: The effect of binding to serum proteins
51. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus
52. Center for Disease Control: Urogenital anomalies in the offspring of women using cocaine during early pregnancy
53. Cocaine abuse in the parturient: What are the anesthetic implications
54. Drug abuse in the parturient
55. Cocaine, dopamine and the endogenous opioid system
56. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe
57. Cocaine induced hypertension in the ewe and response to treatment with labetalol
58. Perioperative care of the cocaine-abusing patient
59. The use of labetalol in the management of cocaine crisis
60. The management of cocaine-associated myocardial ischemia
61. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats
62. Cocaine toxicity and isoflurane anesthesia: Hemodynamic, myocardial metabolic, and regional blood flow effects in swine
63. Cardiovascular disease in the pregnant patient. A new risk factor
64. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse
65. Nitroglycerin in the treatment of cocaine associated chest pain - Clinical safety and efficacy
66. Cocaine and succinylcholine sensitivity: A new caution
67. Anesthesia and maternal substance abuse
68. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. 8. Advanced challenges in resuscitation. 2. Toxicology in ECC
69. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction
70. The puzzle of cocaine's effects following maternal use during pregnancy. Are there reconcilable differences?
71. Speedballs: A new cause of tachycardia and hypertension
72. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: Evidence for adrenergically mediated alterations in coronary artery tone
73. Development of a therapeutic vaccine for the treatment of cocaine addiction
74. Efficacy of a therapeutic cocaine vaccine in rodent models